Randy Scott Bethiel

This inventor holds 39 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Influenza Inhibitors. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 1998-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Randy Scott Bethiel. Retrieved from https://idiyas.com/inventor/randy-scott-bethiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 (Patent Applications = 5)

% Patents Active = 56.4

CIPO Patents = 3

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 7.1

ph-index = 18

Forward Citations = 1,098(Granted Patents)

Location History:

Allston, MA (US) (1998 - 2002)
Arlington, MA (US) (2005)
Cambridge, MA (US) (2002 - 2010)
Bedford, MA (US) (2003 - 2011)
Lexington, MA (US) (2007 - 2020)

Company Filing History:

39 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

Influenza Virus

JAK Inhibitors

Protein Kinase

Serine Proteases

IMPDH Enzyme

c-MET Kinase

Prodrugs

Azaindoles

Pyrrolopyridines

Pyrrolo[2,3-D]pyrimidines

Janus Kinases

c-Jun N-terminal Kinases

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10875855 - Inhibitors of influenza viruses replication (2020-12-29),

2. 10874673 - Inhibitors of influenza viruses replication (2020-12-29),

3. 10039762 - Inhibitors of influenza viruses replication (2018-08-07),

4. 9908878 - Inhibitors of influenza viruses replication (2018-03-06),

5. 9808459 - Inhibitors of influenza viruses replication (2017-11-07),

6. 9518056 - Inhibitors of influenza viruses replication (2016-12-13),

7. 9394302 - Inhibitors of influenza viruses replication (2016-07-19),

8. 9345708 - Inhibitors of influenza viruses replication (2016-05-24),

9. 9051319 - Inhibitors of influenza viruses replication (2015-06-09),

10. 8987454 - Azaindoles useful as inhibitors of JAK and other protein kinases (2015-03-24),

11. 8921376 - Pyrrolopyridines useful as inhibitors of protein kinase (2014-12-30),

12. 8829007 - Inhibitors of influenza viruses replication (2014-09-09),

13. 8722889 - Azaindoles useful as inhibitors of JAK and other protein kinases (2014-05-13),

14. 8686143 - Compounds useful as inhibitors of Janus kinases (2014-04-01),

15. 8580802 - Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases (2013-11-12),

Sure, here is the article about inventor Randy Scott Bethiel:

Title: Innovator Spotlight: Randy Scott Bethiel

Introduction:

Randy Scott Bethiel is a prolific inventor based in Lexington, MA (US), known for his remarkable contributions in the field of pharmaceuticals and antiviral research. With an impressive portfolio of 39 patents to his name, Bethiel has been at the forefront of innovation in inhibiting the replication of influenza viruses.

Latest Patents:

Bethiel's latest patents focus on inhibitors of influenza virus replication. His groundbreaking methods involve inhibiting the replication of influenza viruses, reducing the viral load in biological samples or patients, and treating influenza effectively using compounds represented by Structural Formula (I) or their pharmaceutically acceptable salts. These innovative pharmaceutical compositions have shown promising results in combating influenza.

Career Highlights:

Currently employed at Vertex Pharmaceuticals, Inc., Randy Scott Bethiel has established himself as a key figure in the company's research and development division. His expertise in antiviral compounds and pharmaceutical formulations has led to significant advancements in the field of virology.

Collaborations:

Bethiel has collaborated with notable colleagues such as Luc J Farmer and Tiansheng Wang, further enhancing the scope and impact of his research. The synergistic efforts of these talented individuals have resulted in groundbreaking discoveries and patents that have the potential to revolutionize antiviral treatment strategies.

Conclusion:

In conclusion, Randy Scott Bethiel's dedication to innovation and his relentless pursuit of new antiviral solutions underscore his significance in the pharmaceutical industry. His pioneering work in developing inhibitors of influenza virus replication not only showcases his expertise but also highlights the critical role of inventors in advancing healthcare and combating infectious diseases.

Is there anything else you would like to know about inventor Randy Scott Bethiel or any other topic related to innovations, inventions, inventors, patent attorneys, assignees, or patents?

Profile summary based on public USPTO records.